The proposed offer, comprising units aggregating up to ₹1,340 crore, includes a strategic investor portion capped at 25 per cent of the total issue size
ICICI Prudential AMC has fixed a ₹2,061-₹2,165 price band for its ₹10,600-crore IPO, an OFS by Prudential. The issue opens Friday and implies a ₹1.07-trillion valuation
Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer
AceVector plans to deploy the net proceeds towards marketing and business promotion
The Indian consumers' focus on value has pushed Amazon to develop tools such as value dashboards and gamified in-app experiences - innovations now being adopted in other markets
Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares
Corona Remedies IPO: Check price band, lot size GMP, subscription status, reviews, and other key details here
Once the allotment is finalised, investors who applied for the public offering can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue
Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5
Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies
Prudential will sell up to 49 million shares in the IPO, compared with an earlier plan of 17.7 million shares, ICICI Prudential said in a filing late on Friday
Meesho, Aequs and Vidya Wires drew bids worth nearly Rs 3 trillion, with institutional investors driving subscriptions as high as 120 times the shares on offer
Riding on favourable valuations, strong DII participation, IPO proceeds to cross ₹1.7 trn mark
Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times
IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore
Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times
Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here
Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday
Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore
Valuation of India's largest hospital network is around $12-15 bn. The Issue will comprise fresh issue of shares and a small portion as OFS